Sustainable development in Vedanta Ltd

Vedanta Ltd is one of the world’s leading diversified natural resource company with operating its businesses in India, South Africa, Australia and Namibia. The company is also among the top of its sector with contributing a significant revenue to the economy. The company has been taking step to optimize its productivity by deploying Big data analytics for providing solutions for its efficiency and productivity. Vedanta Limited -Aluminium & Power business is one of India's largest producers of aluminium with an installed capacity of 2.2 mtpa and has an extensive portfolio of value-added aluminium products which are used by a wide gamut of core industries.
The following graph shows the downfall in the share price of the company as the fear of Coronavirus pandemic increase in India. The market sentiments have hit hardly due to the spreading of Coronavirus and the markets have turned red for most of the sessions as the serious lockdown of industries and business projects. The metal & mining industry have been hit hard as the exports and imports of coals, metals and oils have been restricted by the countries to avoid the spread of the COVID-19.

 

The government reforms taken to contain the spread of the Coronavirus in India has been strict as the companies, malls, stores etc.., are shut under the government rule. The fear of the virus spreading has been impacting the purchasing power of the consumers as the discretionary expenses have been reduced by the companies. The graph of Bollinger Bands and Parabolic SAR shows that the band has widened which indicates a scope of change in the share price movements. Over the past few sessions the company’s stock has been bearish but the price movements has not been highly volatile as the markets are also displaying bearish trend globally.

Comments

Popular posts from this blog

WHAT'S IT LIKE TO LIVE IN THE HOSTELS OF CHRIST LAVASA?

PANEL DISCUSSION ON LEADERSHIP & ENTREPRENEURSHIP DEVELOPMENT SKILLS

WEBINAR ON ROLE OF DIGITAL MARKETING IN THE PHARMACEUTICAL SECTOR